PPARγ gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression

American Heart Journal

Volumn 154, Issue 4, 2007, Pages 718-724

  Liu, Yu ^a   Yuan, Zuyi ^a,b   Liu, Yan ^a   Zhang, Jijun ^a   Yin, Ping ^a   Wang, Dongqi ^a   Wang, Yanni ^a   Kishimoto, Chiharu ^c   Ma, Aiqun ^a,b  

^a First Affiliated Hospital   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GELATINASE B; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; ADULT; AGED; ALLELE; ANGIOGRAPHY; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHINESE; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; GENE MUTATION; GENOTYPE; HEART PROTECTION; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; THORAX PAIN; ASIAN; BLOOD; GENETIC POLYMORPHISM; GENETICS; HEART INFARCTION; MIDDLE AGED; PHYSIOLOGY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL MODEL; SYNDROME; VARIANT ANGINA PECTORIS;

AGED; ANGINA PECTORIS, VARIANT; ASIAN CONTINENTAL ANCESTRY GROUP; CHEST PAIN; CORONARY DISEASE; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PPAR GAMMA; RISK ASSESSMENT; SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548794912     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.06.009     Document Type: Article

References (28)

1. Kliewer S.A., and Willson T.M. The nuclear receptor PPAR gamma-bigger than fat. Curr Opin Genet Dev 8 (1998) 576-581
2. Fajas L., Auboeuf D., Raspe E., et al. The organization, promoter analysis, and expression of the human PPAR gamma gene. J Biol Chem 272 (1997) 18779-18789
3. Chawla A., Barak Y., Nagy L., et al. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature 7 (2001) 48-52
4. Clark R.B., Bishop-Bailey D., Estrada-Hernandez T., et al. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J Immunol 164 (2000) 1364-1371
5. Marx N., Schonbeck U., Lazar M.A., et al. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ Res 83 (1998) 1097-1103
6. Ricote M., Huang J., Fajas L., et al. Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci U S A 95 (1998) 7614-7619
7. Ricote M., Li A.C., Willson T.M., et al. The peroxisome proliferator activator-γ is a negative regulator of macrophage activation. Nature 391 (1998) 79-82
8. Jiang C., Ting A.T., and Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998) 82-86
9. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
10. Satterthwaite G., Francis S.E., Suvarna K., et al. Differential gene expression in coronary arteries from patients presenting with ischemic heart disease: further evidence for the inflammatory basis of atherosclerosis. Am Heart J 150 (2005) 488-499
11. Swynghedauw B. Susceptibility-conferring polymorphic genotypes in cardiovascular multifactorial syndromes. Eur Heart J 23 (2002) 271-273
12. Gomez-Zumaquero J.M., Morcillo S., Soriguer F., et al. Pro12Ala polymorphism of the PPAR-γ2 gene is related to increased levels of oxidized low-density lipoprotein (LDL) autoantibodies in patients with type 2 diabetes mellitus. Metabolism 52 (2003) 213-217
13. Iwata E., Yamamoto I., Motomura T., et al. The association of Pro12Ala polymorphism in PPARγ2 with lower carotid artery IMT in Japanese. Diabetes Res Clin Pract 62 (2003) 55-59
14. Ridker P.M., Cook N.R., Cheng S., et al. Alanine for proline substitution in the peroxisome proliferator-activated receptor γ-2 (PPARγ2) gene and the risk of incident myocardial infarction. Arterioscler Thromb Vasc Biol 23 (2003) 859-863
15. Wang X.L., Oosterhof J., and Duarte N. Peroxisome proliferator-activated receptor γ C161→T polymorphism and coronary artery disease. Cardiovasc Res 44 (1999) 588-594
16. Yuan Z., Liu Y., Liu Y., et al. Peroxisome proliferation-activated receptor-γ ligands ameliorate experimental autoimmune myocarditis. Cardiovasc Res 57 (2003) 392-401
17. Yuan Z., Liu Y., Liu Y., et al. Peroxisome proliferator-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells. J Cardiovasc Pharmacol 43 (2004) 868-875
18. Sidhu J.S., Cowan D., Tooze J.A., et al. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease. Am Heart J 147 (2004) 1032-1037
19. Pasterkamp G., Schoneveld A.H., Hijnen D.J., et al. Atherosclerotic arterial remodeling and the location of macrophages and matrix metalloproteinase 1, 2 and 9 in the human coronary artery. Atherosclerosis 150 (2000) 245-253
20. Morishige K., Shimokawa H., Matsumoto Y., et al. Overexpression of matrix metelloproteinase-9 promotes intravascular thrombus formation in porcine coronary arteries in vivo. Cardiovasc Res 57 (2003) 572-585
21. McDermott M.M., Guralnik J.M., Corsi A., et al. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study. Am Heart J 150 (2005) 276-281
22. Hu F.B., Meigs J.B., Li T.Y., et al. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53 (2004) 693-700
23. Wang X.L., Liu S.X., McCredie R.M., et al. Polymorphisms at the 59-end of the apolipoprotein AI gene and severity of coronary artery disease. J Clin Invest 98 (1996) 372-377
24. Mizia-Stec K., Gasior Z., Zahorska-Markiewicz B., et al. Serum tumor necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes. Coron Artery Dis 14 (2003) 431-438
25. Kalela A., Koivu T.A., Sisto T., et al. Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease. Scand J Clin Lab Invest 62 (2002) 337-342
26. Inokubo Y., Hanada H., Ishizaka H., et al. Plasma levels of matrix metelloproteinase-9 and tissue inhibitor of metelloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J 141 (2001) 211-217
27. Meirhaeghe A., Fajas L., Helbecque N., et al. A genetic polymorphism of the peroxisome proliferator activator gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet 7 (1998) 435-440
28. Totonoz P., and Nagy L. Regulation of macrophage gene expression by peroxisome proliferator activator receptor γ: implication for cardiovascular disease. Curr Opin Lipidol 10 (1999) 241-252